INVO Fertility, Inc. Stock-Based Compensation
INVO Fertility, Inc. (IVF) reported Stock-Based Compensation of $162.92 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-06-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-06-02
- INVO Fertility, Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $251.56K, a 40.97% decline year-over-year.
- INVO Fertility, Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $326.92K, a 24.46% decline year-over-year.
- INVO Fertility, Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $325.83K, a 23.96% decline year-over-year.
- INVO Fertility, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-12-31 was $328.97K, a 16.10% decline year-over-year.
- INVO Fertility, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $162.92K.
- INVO Fertility, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $1.62M, a 4.70% increase from fiscal 2021.
- INVO Fertility, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $1.54M, a 35.31% increase from fiscal 2020.
- INVO Fertility, Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $1.14M, a 1534.96% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 54 month | Share-based Payment Arrangement, Noncash Expense 57 month |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $162.92K 10-K · filed 2026-06-02 | |||||||
| 2023-09-30 | $251.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $578.47K derived: sum of 2 quarters · filed 2023-11-13 | $904.30K 10-Q · filed 2023-11-13 | $1.23M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2023-06-30 | $326.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $652.75K 10-Q · filed 2023-08-14 | $981.72K derived: sum of 3 quarters · filed 2023-08-14 | $1.41M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2023-03-31 | $325.83K 10-Q · filed 2023-05-15 | $654.81K derived: sum of 2 quarters · filed 2023-05-15 | $1.08M derived: sum of 3 quarters · filed 2023-11-13 | $1.51M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-12-31 | $328.97K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $755.12K derived: sum of 2 quarters · filed 2023-11-13 | $1.19M derived: sum of 3 quarters · filed 2023-11-13 | $1.62M 10-K · filed 2023-04-17 | ||||
| 2022-09-30 | $426.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $858.94K derived: sum of 2 quarters · filed 2023-11-13 | $1.29M 10-Q · filed 2023-11-13 | $1.68M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $432.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $861.28K 10-Q · filed 2023-08-14 | $1.25M derived: sum of 3 quarters · filed 2023-08-14 | $1.64M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $428.49K 10-Q · filed 2023-05-15 | $820.60K derived: sum of 2 quarters · filed 2023-05-15 | $1.21M derived: sum of 3 quarters · filed 2023-05-15 | $1.60M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $392.11K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $783.31K derived: sum of 2 quarters · filed 2023-04-17 | $1.17M derived: sum of 3 quarters · filed 2023-04-17 | $1.54M 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | $391.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $775.28K derived: sum of 2 quarters · filed 2022-11-14 | $1.15M 10-Q · filed 2022-11-14 | $1.44M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $384.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $760.61K 10-Q · filed 2022-08-15 | $1.05M derived: sum of 3 quarters · filed 2022-08-15 | $1.31M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $376.52K 10-Q · filed 2022-05-16 | $665.33K derived: sum of 2 quarters · filed 2022-05-16 | $921.12K derived: sum of 3 quarters · filed 2022-05-16 | $1.14M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $288.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $544.60K derived: sum of 2 quarters · filed 2022-03-31 | $759.51K derived: sum of 3 quarters · filed 2022-03-31 | $1.14M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $255.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $470.71K derived: sum of 2 quarters · filed 2021-11-15 | $852.19K 10-Q · filed 2021-11-15 | $921.97K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $214.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $596.39K 10-Q · filed 2021-08-16 | $666.18K derived: sum of 3 quarters · filed 2021-08-16 | $666.18K derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $381.48K 10-Q · filed 2021-05-17 | $451.26K derived: sum of 2 quarters · filed 2021-05-17 | $451.26K derived: sum of 3 quarters · filed 2021-05-17 | $451.26K derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $69.79K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $69.79K derived: sum of 2 quarters · filed 2021-03-30 | $69.79K derived: sum of 3 quarters · filed 2021-03-30 | $69.79K 10-K · filed 2021-03-30 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | $93.75K 10-Q · filed 2019-11-14 | $0.00 derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | $0.00 derived: sum of 3 quarters · filed 2020-08-13 | -$1.74M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-15 | $0.00 derived: sum of 2 quarters · filed 2020-05-15 | -$1.74M derived: sum of 3 quarters · filed 2020-05-15 | -$181.66K derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$1.74M derived: sum of 2 quarters · filed 2020-03-30 | -$181.66K derived: sum of 3 quarters · filed 2020-03-30 | $0.00 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$181.66K derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | $1.74M 10-Q · filed 2018-11-14 | ||||
| 2018-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $1.74M 10-Q · filed 2018-08-14 | ||||||
| 2018-03-31 | $181.66K 10-Q · filed 2018-05-15 | |||||||
| 2017-09-30 | $28.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $76.69K derived: sum of 2 quarters · filed 2018-11-14 | $135.93K 10-Q · filed 2018-11-14 | |||||
| 2017-06-30 | $48.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $107.34K 10-Q · filed 2018-08-14 | ||||||
| 2017-03-31 | $59.24K 10-Q · filed 2018-05-15 | |||||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $1.26M derived: sum of 2 quarters · filed 2017-11-14 | $1.26M 10-Q · filed 2017-11-14 | |||||
| 2016-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-09-05 | $1.26M 10-Q · filed 2017-09-05 | $1.26M 10-Q · filed 2017-08-10 | |||||
| 2016-03-31 | $0.00 10-Q · filed 2017-09-05 | |||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-05 | $0.00 derived: sum of 2 quarters · filed 2017-09-05 | $0.00 10-Q · filed 2017-09-05 | |||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-09-05 | $0.00 10-Q · filed 2017-09-05 | ||||||
| 2015-03-31 | $0.00 10-Q · filed 2017-09-05 | |||||||
| 2014-09-30 | $0.00 derived: 10-K 9 month − 10-K 6 month · filed 2017-03-17 | $0.00 derived: sum of 2 quarters · filed 2017-03-17 | $0.00 10-K · filed 2017-03-17 | |||||
| 2014-06-30 | $0.00 derived: 10-K 6 month − 10-K 3 month · filed 2017-03-17 | $0.00 10-K · filed 2017-03-17 | ||||||
| 2014-03-31 | $0.00 10-K · filed 2017-03-17 | |||||||
| 2013-09-30 | $10.00K derived: 10-K 9 month − 10-K 6 month · filed 2017-03-17 | $45.04K derived: sum of 2 quarters · filed 2017-03-17 | $105.04K 10-K · filed 2017-03-17 | |||||
| 2013-06-30 | $35.04K derived: 10-K 6 month − 10-K 3 month · filed 2017-03-17 | $95.04K 10-K · filed 2017-03-17 | ||||||
| 2013-03-31 | $60.00K 10-K · filed 2017-03-17 | |||||||
| 2012-09-30 | $0.00 derived: 10-K 9 month − 10-K 6 month · filed 2017-03-17 | $35.92K derived: sum of 2 quarters · filed 2017-03-17 | $35.92K 10-K · filed 2017-03-17 | |||||
| 2012-06-30 | $35.92K derived: 10-K 6 month − 10-K 3 month · filed 2017-03-17 | $35.92K 10-K · filed 2017-03-17 | ||||||
| 2012-03-31 | $0.00 10-K · filed 2017-03-17 | |||||||
| 2011-09-30 | $0.00 derived: 10-Q 57 month − 10-Q 54 month · filed 2011-11-21 | $379.46K 10-Q · filed 2011-11-21 | ||||||
| 2011-06-30 | $379.46K 10-Q · filed 2011-08-22 | |||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | $81.00K 10-Q · filed 2011-11-21 | ||||||
| 2010-06-30 | $81.00K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |